SUMO2 and hepatocellular carcinoma: A recent study showed that the overexpression of SUMO2/3 promoted the proliferation of HCC cells via upregulating the protein level of HSP27, and silencing SUMO2/3 in the cells impaired their proliferative activity [29], supporting the aforementioned enrichment results that SUMO2 might regulate the cell cycle in the disease.